drugset
drugset / Trial / NCT00689442

Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

NCT00689442 ↗

Phase 2 Completed 105 enrolled Akros Pharma Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate safety of JTT-705 and to demonstrate efficacy of JTT-705 compared with placebo when co-administered with atorvastatin 20 mg in patients with low HDL

Timeline

Start
2004-01
Primary completion
2004-11
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Dalcetrapib Small molecule 600 mg Oral
Comparator Atorvastatin Small molecule 20 mg Oral

Indications

hyperlipidemia